Trial Details
TERMINATEDBasic Information
| Clinical ID | c613 |
|---|---|
| Identifier | NCT02849951 |
| Trial Title | A Study to Investigate the Safety and Efficacy of LT-02 in Patients With Mesalamine Refractory Ulcerative Colitis (UC) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | DRUG: LT-02|DRUG: LT-02 Placebo |
Participant Information
| Sponsor | Prometheus Laboratories |
|---|---|
| City | Phoenix |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE3 |
Time Information
| Start Date | 2025-07-16 |
|---|---|
| Primary Completion Date | 2025-03-19 |
| Completion Date | 2025-08-19 |